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Introduction
Human intellectual disability, formally deﬁned as full-
scale IQ of 70 and below (Kleefstra and Hamel 2005;
Chelly et al. 2006; Raymond 2006), is caused in many
cases by rare, highly-penetrant loss-of-function mutations
affecting a set of identiﬁed genes (Chiurazzi et al. 2004;
Inlow and Restifo 2004). Lehrke (1972, 1974) ﬁrst sug-
gested that such ‘mental retardation genes’, especially
X-linked ones, might exhibit variants affecting ‘intelli-
gence’ (deﬁned by clinicians in terms of IQ) in nonclinical
populations. This prediction was based on early studies
showing an excess of males over females with intellectual
disability, a wider distribution of IQ in males, and segrega-
tion patterns of intellectual disability within families, and
it has since been reiterated by other authors as more
evidence on the genetic bases of cognitive abilities and
intellectual disability has become available (Turner and
Partington 1991; Turner 1996; Lubs 1999; Neri and Opitz
2000; Spinath et al. 2004; Ropers and Hamel 2005; Arden
and Plomin 2006; Plomin et al. 2006). Darwin’s own pedi-
gree has indeed been used as an example of potential
X-linked inheritance of high cognitive ability (Turner
1996), given that such abilities have been traced down
female lines from Josiah Wedgwood to Charles Darwin,
and from Erasmus Darwin to Francis Galton.
Zechner et al. (2001) extended Lehrke’s hypothesis in
proposing that X-linked intellectual disability genes ‘have
had a major impact on the rapid development of cognitive
abilities during human evolution’, an idea inspired by the
apparent differential presence of genes with cognitive
functions on the X chromosome and by the exposure of
X-linked genes in males directly to selection (Graves et al.
2002; Vicoso and Charlesworth 2006). The X chromosome
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Abstract
Previous studies have postulated that X-linked and autosomal genes underlying
human intellectual disability may have also mediated the evolution of human
cognition. We have conducted the ﬁrst comprehensive assessment of the extent
and patterns of positive Darwinian selection on intellectual disability genes in
humans. We report three main ﬁndings. First, as noted in some previous
reports, intellectual disability genes with primary functions in the central ner-
vous system exhibit a signiﬁcant concentration to the X chromosome. Second,
there was no evidence for a higher incidence of recent positive selection on
X-linked than autosomal intellectual disability genes, nor was there a higher
incidence of selection on such genes overall, compared to sets of control genes.
However, the X-linked intellectual disability genes inferred to be subject to
recent positive selection were concentrated in the Rho GTP-ase pathway, a key
signaling pathway in neural development and function. Third, among all intel-
lectual disability genes, there was evidence for a higher incidence of recent
positive selection on genes involved in DNA repair, but not for genes involved
in other functions. These results provide evidence that alterations to genes in
the Rho GTP-ase and DNA-repair pathways may play especially-important
roles in the evolution of human cognition and vulnerability to genetically-based
intellectual disability.
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compared to autosomes (Vallender and Lahn 2004;
Nguyen and Disteche 2006), and exhibits a stronger overall
signal of positive selection than autosomes (Nielsen et al.
2005; Wang et al. 2006; Zhang et al. 2006a), but the degree
to which such ﬁndings apply to X-linked genes affecting
intellectual disability or cognitive functions remains
unknown.
Despite a concentration of intellectual disability genes
on the X chromosome that is apparently not due to
ascertainment bias (Zechner et al. 2001; Ge ´cz 2004; Inlow
and Restifo 2004; Ropers and Hamel 2005; Willems 2007;
Delbridge et al. 2008), the hypothesis that genes underly-
ing human intelligence differentially reside on the X chro-
mosome, and the degree to which ‘intellectual disability’
genes in general have been involved in the evolution
of human cognition, have yet to be systematically
investigated (Hook 1996; Willems 2007). Indeed, the only
previous evidence bearing more or less directly on these
hypotheses includes a study by Boda et al. (2002) showing
that four X-linked mental retardation genes are involved
in activity-dependent neuronal plasticity, and data linking
alleles of the autosomal SSADH gene (coding for succi-
nate semialdehyde dehydrogenase) to both mental retar-
dation (via deactivating mutations) and high versus
normal IQ (via variants of a functional polymorphism,
with the high-IQ allele derived in humans) (Akaboshi
et al. 2003; Gibson et al. 2003; Plomin et al. 2004; Blasi
et al. 2006; Leone et al. 2006; see also De Rango et al.
2008). The only previous study on the molecular-evolu-
tionary genetics of intellectual disability (Kitano et al.
2003) investigated patterns of gene diversity for 10
X-linked loci in chimps and humans, and inferred high
levels of functional constraint on most of the genes, but
possible evidence of positive selection on one gene,
FMR2, along the human lineage. Analyses of molecular-
evolutionary patterns for intellectual-disability genes
should yield insights into the genetic architecture of
human intelligence (Deary et al. 2009), with important
implications for the forms of genetic perturbation that
can disrupt this complex human phenotype (Inlow and
Restifo 2004; Ropers and Hamel 2005; Ge ´cz et al. 2009).
In this study, we present the results of tests for positive
Darwinian selection along the human lineage on a com-
prehensive set of intellectual disability genes, compiled by
Inlow and Restifo (2004), Appendix 1. Using tests for
selective sweeps from the human HapMap data (Voight
et al. 2006) and maximum likelihood tests for adaptive
protein evolution (Yang 2007; Nickel et al. 2008), we
evaluate the hypothesis that X-linked intellectual disability
genes, or intellectual disability genes in general, have been
differentially subject to positive selection in recent human
evolution. We also investigate patterns of selection in
relation to gene function, to determine if functional sub-




We based our analysis on the list of 282 intellectual dis-
ability genes compiled by Inlow and Restifo (2004), which
also includes information on the biological functions of
the genes involved. Mitochondrial genes were not ana-
lyzed, and sufﬁcient data for analysis were unavailable for
seven autosomal genes, leaving a total of 264 genes, 44 of
which were X-linked.
Tests for positive selection
We used two approaches to infer positive selection during
human evolution, the iHS test for recent selective sweeps
developed by Voight et al. (2006), and maximum likeli-
hood tests of adaptive protein evolution as deployed in
PAML (Yang 2007; Nickel et al. 2008). For the iHS tests,
we used data from the human haplotype map (phase I),
the data source for which genome-wide iHS values are
currently available for both the autosomes and X chro-
mosome (Voight et al. 2006). Results from available phase
II data analyses were closely similar, as described below.
For the three genotyped populations, evidence of positive
selection is indicated by the tendency of recently-selected
alleles to sweep a set of tightly-linked sites to relatively
high frequency. Our criterion for positive selection in
these data was a probability value of 0.05 or lower for
one or more of the three populations. Gene-speciﬁc
probability values of the iHS statistics, calculated and
presented in Haplotter (Voight et al. 2006; http://
hg-wen.uchicago.edu/selection/haplotter.htm), are empiri-
cally derived, separately for the X chromosome and the
autosomes, given their different effective population sizes
and inheritance systems. For the maximum-likelihood
tests of adaptive protein evolution, we used branch-site
models in PAML (Yang 2007) as calculated and deployed
in PAML browser (Nickel et al. 2008; http://mendel.
gene.cwru.edu/adamslab/pbrowser.py), focusing on the
hypothesis of adaptive protein evolution along the human
lineage. These tests were based on aligned sequence from
a subset of the taxa chimpanzee, orangutan, rhesus maca-
que, mouse, rat, rabbit, dog, cow, armadillo, elephant,
tenrec, opossum, chicken, frog, zebraﬁsh, tetraodon and
fugu, with the great majority of the genes including data
at least from human, chimpanzee, orangutan, macaque,
rat, mouse, dog and cow.
We tested for a differential incidence of positive selec-
tion on intellectual disability genes in two ways. First, we
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subject to positive selection between: (a) intellectual dis-
ability genes and (b) control genes derived from a ran-
dom sample of genes in the Panther gene-ontology (GO)
category ‘neuronal activities’ (Mi et al. 2005). This GO
category of genes should be most similar, in terms of
function, to genes known to mediate intellectual disabil-
ity. We also note that the category ‘developmental pro-
cesses’ yielded very similar results as regards the
proportion of control genes inferred as positively selected.
Second, we also used another, larger set of control
genes, derived from the gene-expression database http://
symatlas.gnf.org/SymAtlas/ (Su et al. 2004) based on the
criterion that the genes exhibited at least 1.25· higher
expression in the human brain than in other tissues. With
this set of controls, which includes a large diversity of
genes differentially underlying brain functions, we were
able to robustly compare the proportions of genes
inferred as selected (using both iHS and PAML-based
tests) between intellectual disability genes and control
genes, separately for genes on the X chromosome and
genes on autosomes. All tests were two-tailed.
Results
Overall, 33 genes exhibited a signiﬁcant signature of posi-
tive selection in one or more of the HapMap populations
and 231 genes yielded nonsigniﬁcant results (Table 1).
The proportion of intellectual disability genes inferred as
subject to positive selection using iHS did not differ
between X-linked genes (4, 9.8% of 41) and autosomal
genes (29, 13% of 223; Fisher’s Exact test, P = 0.79), and
similar results were obtained using human-lineage speciﬁc
maximum-likelihood tests (2, 6.1% of 33 X-linked genes
inferred as selected at P < 0.05 (DMD and L1CAM),
compared to 5, 2.6% of 189 autosomal genes (LAMA2,
MYO5A, SLC12A1, TSHR and TTF1), Fisher’s exact test,
P = 0.29). Overall, the proportion of intellectual disability
genes inferred as subject to positive selection using iHS
(33, 12.5% of 264) did not differ signiﬁcantly from the
proportion of neuronal-activities control genes inferred as
selected (28, 8.8% of 330; Fisher’s Exact test, P = 0.13).
Similar results were obtained using human-lineage spe-
ciﬁc maximum-likelihood tests: 7 (3.2%) of 222 intellec-
tual disability genes were inferred as positively selected,
compared to 9 (2.8%) of 316 neuronal-activities control
genes (Fisher’s exact test, P = 0.68).
Using the set of differentially brain-expressed genes as
controls, the proportion of X-linked intellectual disability
genes inferred as selected using iHS (9.8%, as noted
above) did not differ from the proportion of control
X-linked genes inferred as selected (9, 6.6% of 136; Fish-
er’s exact test, P = 0.85). Similarly, the proportion of
X-linked intellectual disability genes inferred as selected
using human-lineage speciﬁc maximum-likelihood tests
(6.1%) did not differ from proportion of control X-linked
genes inferred as selected (4, 4% of 101; Fisher’s exact
test, P = 0.84). The proportion of autosomal intellectual
disability genes inferred as selected using iHS (13%) did
not differ from the proportion of autosomal control genes
inferred as selected (22, 10.3% of 214; Fisher’s exact test,
P = 0.23). The proportion of autosomal intellectual
disability genes inferred as selected using human-lineage
speciﬁc maximum-likelihood tests (5, 2.6% of 189) like-
wise did not differ from the proportion of autosomal
control genes inferred as selected (2, 1.2% of 166; Fisher’s
exact test, P = 0.28).
Taken together, these results indicate that there is no
evidence for enhanced signals of selection on X-linked
intellectual disability genes, or on intellectual disability
genes overall, compared to control genes.
Of the genes in the full data set, 127 are reported by
Inlow and Restifo (2004) to exhibit primary functions in
the central nervous system, and these exhibit a signiﬁcant
concentration on the X chromosome: 69.7% of X-linked
intellectual disability genes show primary CNS function,
compared to 49.2% of autosomal ones (Table 2). A sig-
niﬁcant concentration of X-linkage is also apparent for
signaling pathway genes (Table 2), but this pattern may
be caused by joint functions of these genes in the CNS
and in signaling pathways: 6 (75%) of 8 X-linked signal-
ing pathway genes also exhibited CNS functions, as did
14 (87.5%) of autosomal ones. Intellectual disability
genes involved in lysosomal functions, DNA repair,
Table 1. Mental retardation genes from the compilation of Inlow
and Restifo (2004), Appendix 1 that show evidence of recent positive
selection in one or more HapMap populations (Voight et al. 2006).
X-linked
FACL4 (1 Yri), FGD1 (1 Ceu), FMR1 (2 Ceu), OPHN1 (3 Ceu)
Autosomal
AMT (64 Asn, 4 Yri, 0.0526), ALG12 (7 Ceu, 2 Asn, 0.0502), ASL (13
Asn, 14 Yri), CBS (2 Ceu), CLN1 (5 Asn, 2 Yri, 0.064) CREBBP (1
Yri), DBT (5 Ceu), DUOX2 (6 Ceu), ERCC8 (3 Ceu), FANCA (3 Yri),
FANCC (1 Yri & 1 Asn), FOXE1 (4 Yri), GCS1 (20 Ceu), GNPAT (4
Ceu), GPH (7 Ceu, 6 Yri, 0.080), GSS (5 Ceu, 6 Asn), GUSB (13 Yri,
13 Asn), HEXA (7 Ceu), MYO5A (4 Ceu), NBS1 (2 Ceu & 2 Yri),
NDUFS4 (1 Ceu, 1 Yri), NDUFV1 (24 Asn), PEX1 (7 Yri, 3 Ceu 0.094),
POMT1 (2 Yri), PPOX (14 Yri), SARA2 (5 Yri), SLC12A1 (2 Ceu),
SLC12A6 (5 Ceu), TTF1 (2 Ceu)
Shown after each gene is the number of contiguous genes in the
inferred selective sweep, and the population showing evidence of
selection at P < 0.05. Population and P-value data are also presented
for these genes from any additional population showing evidence of
selection at marginally nonsigniﬁcant P-values of 0.05 < P < 0.10.
Ceu = European, Yri = African, Asn = Asian.
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cation showed no evidence of an increased frequency of
X-linkage.
Intellectual disability genes with primary CNS functions
did not show evidence of enhanced signals of recent posi-
tive selection in the human lineage, nor did genes with
functions in lysosomal activities, metabolism, transcrip-
tion regulation, or protein modiﬁcation. By contrast,
nearly half (44%) of the genes (ERCC8, FANCA, FANCC,
and NBS1, all autosomal) with biological functions in
DNA repair showed signals of recent positive selection,
which was signiﬁcantly higher than the proportion for
genes with other functions (11.4%, Table 2). The FANCA
and ERCC8 genes remained signiﬁcant in analyses of
phase II data (at P values of 0.023 and 0.033 respectively),
and the FANCC and NBS1 showed borderline empirical P
values of 0.057 and 0.056 respectively. Both of these latter
genes, however, also showed evidence of selection on spe-
ciﬁc SNPs in phase II data (Voight et al. 2006). Deﬁnite
or putative primary CNS function is also reported for all
nine of the DNA repair genes in the data set, which sug-
gest that joint functions in DNA repair and the CNS may
represent the actual functional category of intellectual
disability genes showing an enhanced signal of positive
selection. Such joint functions are well documented for
key genes in the BRCA/FANC pathway; for example, the
Fanconi anemia complex genes, as well as BRCA1 and
BRCA2, play key roles in neural stem cell development
and function (Frappart et al. 2007; Sii-Felice et al. 2008;
Pulvers and Huttner 2009). Overall, four (33%) of 12 of
the known BRCA/FANC genes exhibit evidence of posi-
tive selection at P < 0.05 from the phase II HapMap data
(BRCA1, FANCA, FANCE, and FANCN), as do two of
the three key genes directly upstream of this pathway
(ATM and CHEK2), and RAD51, which interacts directly
with a domain of BRCA1 subject to adaptive amino acid
evolution (Fleming et al. 2003).
The four X-linked genes inferred here as subject to
positive selection also appear to represent a speciﬁc func-
tional subset of intellectual disability genes, in that three
of these genes, FGD1, FMR1, and OPHN1, are involved
in the Rho GTPase signal transduction pathway (Negishi
and Katoh 2005; Renieri et al. 2005). Data on positive
selection are available in our dataset for seven X-linked
genes involved in the Rho GTP-ase pathway; three
(42.8%) of these genes have thus been inferred as
selected, compared to one selected X-linked gene (2.9%)
among the 34 X-linked genes not in this pathway (Fish-
er’s exact test, P = 0.012). A more general pattern of
recent positive selection involving genes involved in the
Rho GTPase pathway is suggested by the ﬁnding that ﬁve
of the 16 known ARHGEF genes (which critically regulate
this pathway) show evidence of selection at P < 0.05 in
one or more population of the phase II HapMap data
(Voight et al. 2006), and four of the 11 ARHGEF genes
that are not signiﬁcant at the 0.05 level show nonsigniﬁ-
cant trends (0.05 < P < 0.10).
Discussion
We have conducted the ﬁrst comprehensive tests for posi-
tive selection on genes known to underlie human intellec-
tual disability, to evaluate the hypothesis that some of
these genes may also have been involved in the adaptive
evolution of human cognition. A primary result of these
tests is that there is no evidence for an enhanced signal of
recent positive selection on intellectual disability genes
considered as a whole, or for the subset of X-linked ones,
despite the increased tendency of ascertained X-linked
intellectual disability genes to exhibit functions in the
central nervous system. These ﬁndings support the
hypothesis that intellectual disability genes do not gener-
ally represent adaptively-evolving ‘intelligence genes’, but
instead represent genes with important effects on cognitive
Table 2. Data on chromosomal position (X linked vs autosomal) and proportions of genes inferred as subject to recent positive selection, as evi-
denced by selective sweeps in humans, for mental retardation genes with different biological functions as listed in Inlow and Restifo (2004),
Appendix 1.





CNS 23/34 104/214 0.043 18/123 15/130 0.58
Lysosomal 2/44 27/225 0.19 3/29 29/240 1.0
DNA repair 0/44 9/227 0.36 4/9 29/255 0.016
Metabolic 10/44 85/227 0.083 9/94 24/170 0.34
Transcription regulation 3/43 18/226 0.76 3/21 30/241 0.74
Signaling pathway 13/43 20/226 0.0004 2/30 31/232 0.39
Protein modiﬁcation 0/44 17/224 0.084 3/17 30/244 0.46
Fisher’s exact test was used to compare proportions. Biological functions listed as uncertain (with a ‘‘?’’) in Inlow and Restifo (2004), Appendix 1
are not included in the compilations, and seven genes have data on chromosomal location and biological function, but no data on the presence
or absence of positive selection.
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tive loss-of-function mutations that are presumably
selected against (Kitano et al. 2003; Tarpey et al. 2009).
Our results are also generally consistent with previous
studies demonstrating notable selective constraints on pro-
tein-coding brain-expressed genes in humans (Nielsen
et al. 2005; Shi et al. 2006; Wang et al. 2007).
Despite the apparent lack of enhanced signals of posi-
tive selection across all intellectual disability genes, two
speciﬁc categories of intellectual disability genes, (i)
X-linked genes in the Rho GTPase pathway (FGD1,
FMR1, and OPHN1), and (ii) autosomal genes involved
in DNA repair (FANCA, FANCC, NBS1, and XRCC8),
show signiﬁcantly increased frequencies of recent positive
selection, from the HapMap analyses, compared to other
categories. These ﬁndings suggest that speciﬁc subsets of
intellectual disability genes have been subject to positive
selection in humans, such that they may provide
important insights into the molecular-evolutionary and
developmental bases of human cognition.
X-linked Rho GTPase genes
Rho GTPases function as molecular switches that mediate
the activation of signal transduction pathways underlying
cytoskeletal organization, cellular migration, and cell
shape remodeling during differentiation, with especially-
notable roles in neurodevelopment via their functions in
dendritic spine elongation and cell cycle dynamics (Boett-
ner and Van Aelst 2002; van Galen and Ramakers 2005;
Govek et al. 2005; Negishi and Katoh 2005; Linseman and
Loucks 2008). Genes in the Rho GTPase pathway repre-
sent the largest common functional category of X-linked
intellectual disability genes, and given this pattern,
Ramakers (2002) suggested that such genes may be
involved in the development and evolution of normal
human cognition, such that some mutations might
enhance cognitive functions. In accordance with this
hypothesis, pharmaceutical activation of Rho GTPases in
mice can lead to enhanced learning and memory, through
alterations in the actin cytoskeleton and synaptic plasticity
(Diana et al. 2007).
We have reported evidence of recent positive selection
on three X-linked genes, FGD1, FMR1, and OPHN1, each
of which codes for a protein product that acts as an
effector of Rho GTPase activity (Table 3). Some evidence
consistent with positive selection has been reported for
FMR1, in the contexts of an expanded length of trinu-
cleotide repeats in primates compared to other mammals
(Eichler et al. 1995), the presence of 74 ﬁxed differences
between humans and great apes (Mathews et al. 2001), and
high levels of linkage disequilibrium in some human popu-
lations (Eichler et al. 1995; Kunst et al. 1996; Mathews
et al. 2001). Chen et al. (2003) also reported that the efﬁ-
ciency of translation is highest with 30 trinucleotide repeats
in the upstream region, which is also the modal number
across human populations, a pattern consistent with stabi-
lizing selection on repeat number. Evidence consistent with
positive selection has also been reported for the OPHN1
gene by Wang et al. (2006), who described evidence of a
selective sweep in this gene in humans; and by Tarpey et al.
(2009), who used the McDonald-Kreitman test. Kitano
et al. (2003) inferred that this gene underwent one nonsyn-
onymous and one synonymous substitutions in the human
lineage, compared to an absence of nonsynonymous
changes in chimpanzees and orangutans.
FGD1, FMR1, and OPHN1 exhibit several notable
similarities in their phenotypic effects when subject to
loss-of-function mutations, and in their neurodevelop-
mental functions. Thus, for all three genes intellectual dis-
ability includes effects on brain size (macrocephaly), facial
features (Renieri et al. 2005) and genital development as
well as cognitive capacities, and their developmental
effects involve alterations to dendritic spine morphology
and, for FMR1 and OPHN1, glutamatergic signaling
(Table 3). These developmental and phenotypic similari-
ties are intriguing and suggest that the causes of positive
selection on these genes may involve alterations of com-
mon neurogenetic pathways. This hypothesis could be
evaluated by testing for cognitive or neurological effects
of the selected versus nonselected haplotypes in humans,
and by testing for positive selection using a larger subset
of genes, including genes not previously associated with
intellectual disability, that interact functionally with the
gene products of FGD1, FRM1, and OPHN1. More
generally, studies of positive selection focusing on genes
in the Rho GTP-ase signaling pathway may provide
additional insights into whether alterations to genes in
this pathway have played an important role in the
evolution of human brain size and cognition. Adaptive
evolutionary changes to Rho GTPase genes might be
expected to occur differentially for genes on the X chro-
mosome, given the exposure of such genes directly to
selection in males (Vicoso and Charlesworth 2006), which
may contribute to the pattern of positive selection that
we have described here.
Autosomal DNA repair genes
DNA repair was the only speciﬁc functional category of
intellectual disability genes in the compilation of Inlow
and Restifo (2004) to exhibit an enhanced signal of posi-
tive selection. Wang and Moyzis (2007) reported evidence
of (balancing) selection on two of the genes inferred as
selected in our study, FANCC and ERCC8, and Wang
et al. (2006) described evidence of positive selection on
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Wang et al. (2006) also reported a general over-represen-
tation of cell cycle genes in their surveys of positive selec-
tion along the human lineage. As noted above, DNA
repair genes underlying intellectual disability also exhibit
functions in the development of the central nervous sys-
tem, which are evidenced by pleiotropic effects of loss of
function mutations on both neurodevelopment and pre-
disposition to cancer (Balajee 2006). The DNA repair
genes inferred here as subject to selection are involved in
the coordination of responses to DNA damage during cell
division (e. g., McKinnon and Caldecott 2007; Wang
2007), with impaired repair and subsequent cell death
during growth of the brain being responsible at least in
part for effects on the expression of the intellectual dis-
ability phenotype (e. g., Frappart et al. 2007; Lee et al.
2007).
Details of the phenotypic effects and functional roles of
the four positively-selected intellectual disability genes
involved in DNA repair are described in Table 3. Of
particular interest is the presence of microcephaly in
intellectual disability due to loss-of-function mutations in
all four of these genes, linkages of all four genes to
aspects of aging, and the phenotypic and etiologic overlap
of Fanconi Anemia (due to mutations in FANCA and
FANCC) and Nijmegen Breakage Syndrome (due to
mutations in NBS1) (Gennery et al. 2004), with both syn-
dromes involving impaired responses to DNA damage.
These three genes represent components of DNA-damage
response and repair pathways (D’Andrea and Grompe
2003; Narod and Foulkes 2004; McKinnon and Caldecott
2007; Wang 2007; Garcı ´a and Benı ´tez 2008) that also
include the microcephaly-associated, positively-selected
genes MCPH1 (Evans et al. 2005), and ATM (Gilad et al.
1998; Frappart et al. 2005; Voight et al. 2006), as well as
the genes BLM, BRCA1, RAD51, CHEK1 and CHEK2, all
of which show evidence of selection in recent human evo-
lution (Huttley et al. 2000; Bustamante et al. 2005; Wake-
ﬁeld et al. 2005; Voight et al. 2006). Cochran et al. (2006)
also describe evidence that some Ashkenazi-concentrated
mutations, differentially found for genes in DNA repair
pathways including the FANC pathway genes FANCC,
Table 3. Key characteristics of intellectual disability genes that have been inferred as subject to recent positive selection in the human lineage.
Gene Phenotypic effects Developmental-genetic functions
Genes in Rho-GTPase pathway
FGD1 Mutations cause Aarskog-Scott syndrome (FacioGenital
Dysplasia), which involves macrocephaly and genital
anomalies (Schwartz et al. 2000; Orrico et al. 2004;
Bottani et al. 2007)
FGD1 gene product acts as upstream effector of Rho
GTP-ases, and is involved in neurite outgrowth and
dendritic spine development (van Galen and Ramakers
2005)
FMR1 Mutations cause Fragile X syndrome, which involves
macrocephaly, macroorchidism (large testis), reduced
cerebellar vermis, and a high incidence of autism
(Terracciano et al. 2005; Belmonte and Bourgeron
2006)
FMR1 gene product, FMRP, interacts with CYFIP1,2,
which mediate Rho GTPase activation (Billuart and
Chelly 2003); mental retardation involves altered
glutamatergic signaling, and immature dendritic
spines (van Galen and Ramakers 2005)
OPHN1 Mutations involve cerebellar hypoplasia, hypogonadism,
and macrocephaly in a notable proportion of cases
(Chiurazzi et al. 2004; Chabrol et al. 2005; Kleefstra
and Hamel 2005; Zanni et al. 2005)
OPHN1 gene product regulates RhoA activity, affects
glutamatergic signaling; mouse mutants show
immature dendritic spines (Govek et al. 2005; Chabrol
et al. 2005; Zanni et al. 2005; Khelfaoui et al. 2007)
Genes in DNA repair pathways
FANCA & FANCC Mutations cause Fanconi Anemia, an autosomal
recessive condition that involves microcephaly, growth
retardation, bone marrow failure, skeletal
malformations and increased cancer risk (Gennery
et al. 2004; Wang 2007)
FANC genes maintain genomic stability and are
required for neural stem cell maintenance in brain
development; aging of stem cell pools may underlie
Fanconi Anemia phenotypes (Sii-Felice et al. 2008)
NBS1 Mutations cause Nijmegen Breakage syndrome, an
autosomal recessive condition characterized by
microcephaly, immunodeﬁciency, increased cancer
risk, and growth retardation (Gennery et al. 2004; De-
muth and Digweed 2007; O’Driscoll et al. 2007)
NBS1 gene product maintains genomic stability via
repair of double-stranded DNA breaks, and helps to
maintain telomeres (Matsuura et al. 2004; Zhang
et al. 2006b); interacts closely with ATM gene product
in DNA damage response pathway (Diﬁlippantonio
and Nussenzweig 2007)
ERCC8 Mutations are one cause of Cockayne syndrome, an
autosomal recessive condition involving microcephaly,
growth retardation, hypogonadism, and symptoms of
premature aging (Rapin et al. 2006; Niedernhofer
2008)
ERCC8 gene product functions in repair of damage in
actively-transcribed genes (Laine ´ and Egly 2006) and
repair of oxidative DNA damage (D’Errico et al. 2007)
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enhanced cognition in this genetic isolate.
Additional microcephaly-associated genes that have
been subject to apparent positive selection in the human
lineage, such as AHI1 (Ferland et al. 2004; Tang 2006),
ASPM (Zhang 2003; Mekel-Bobrov et al. 2005), CASK
(Voight et al. 2006; Najm et al. 2008) CENPJ (Woods
et al. 2005), CDK5RAP2 (Woods et al. 2005), Cernunnos-
XLF (Pavlicek and Jurka 2006; Zha et al. 2007), NDE1
(Feng and Walsh 2004; Voight et al. 2006), NIPBL (Borck
et al. 2006; Wang et al. 2006) PCNT (Voight et al.; Rauch
et al. 2008), and SHH (Hehr et al. 2004; Dorus et al.
2006), are also involved in cell cycle progression, but
appear to mediate brain size through other DNA repair
pathways, through effects on centrosome function, or via
other neurodevelopmental processes (Woods et al. 2005;
Cox et al. 2006; Fish et al. 2006; Pavlicek and Jurka 2006;
Grifﬁth et al. 2008). The mechanisms whereby such
microcephaly genes cause altered brain development
require further study, but they appear to involve the sur-
vival and maintenance of neural progenitor cells, rates of
apoptosis in neural development, efﬁciency and timing of
symmetric and asymmetric neural cell divisions, depletion
of neural stem cell pools, and tradeoffs between cell pro-
liferation and repair (Korhonen et al. 2003; Bond and
Woods 2006; Cox et al. 2006; Tang 2006; Lee et al. 2007;
Grifﬁth et al. 2008; Sii-Felice et al. 2008; Stiff et al. 2008).
The clearest potential links of such processes to cognition
are positive correlations between brain size and intelli-
gence within humans (Witelson et al. 2006; Narr et al.
2007) as well as across nonhuman primate species (Dea-
ner et al. 2007), and data showing that IQ is positively-
associated with rapidity of growth in thickness of the
cerebral cortex during human childhood (Shaw et al.
2006).
Intellectual disability associated with the autosomal
DNA repair genes analyzed here is due to recessive
mutations in both sexes, in contrast to X-linked
mutations which are manifested and subject to selection
predominantly in males. O’Driscoll et al. (2007) and
O’Driscoll (2008) describe evidence that haploinsufﬁcien-
cy of such DNA repair genes is sufﬁcient to cause nota-
ble phenotypic effects, which suggests that adaptive
mutations may be expressed as dominant or codominant
mutations subject to strong selection. A possible example
is MCPH1, which exhibits a common, derived single
nucleotide polymorphism associated with larger cranial
volume in males of an Asian population, although no
signal of recent positive selection was detected in the
vicinity of this marker (Wang et al. 2008). More gener-
ally, haplotypes of ERCC8, FANCA, FANCC and NBS1
subject to apparent positive selection should represent
good candidates for genetic variants with effects on
brain size and cognitive capacity in nonclinical human
populations.
Conclusions
Interpretation of signals of positive selection, such as the
ones described here, is subject to several important cave-
ats (Hughes 2007). First, the time scale of inferences from
HapMap data is on the order of several tens of thousands
of years (Voight et al. 2006), while the fossil record pro-
vides evidence of human anatomical modernity by about
100 000–80 000 years ago (Bouzouggar et al. 2007), with
large brain size itself evolving considerably earlier (Right-
mire 2004). These lines of evidence imply that signals of
selection inferred in this study would be related to aspects
of brain function not evident from the archeological
record, which is broadly consistent with an acceleration
of positive selection in humans over the past 10 000 or so
years (Hawks et al. 2007). Second, high-density SNP
genotyping across multiple populations are required for
robust inference and localization of selective effects, and
inferences regarding the causes of selection require func-
tional-genomic or ecological-genomic data (Hughes
2007), such as localization of signals to particular func-
tional domains. Third, given strong pleiotropic effects of
genes across multiple phenotypes, such as cancer predis-
position and brain development (Gennery et al. 2004;
McKinnon and Caldecott 2007), or brain and gonadal
functions (Guo et al. 2003, 2005; Meizel 2004), it is chal-
lenging to ascribe selective effects of particular genetic
variants to speciﬁc phenotypes. Despite these limitations,
our study provides useful new insights into the evolution-
ary-genetic bases of intellectual disability, in showing that
signals of recent positive selection on intellectual disability
genes are enhanced for two functional categories of gene.
These ﬁndings suggest that allelic variants of some types
of intellectual disability genes may have mediated the
evolution of human brain size and cognition, and they
provide a clear focus for future studies along these lines.
In addition to providing insights into the evolution of
human intellectual capacities, our results may also be use-
ful in ascertaining the genetic bases of idiopathic cases of
intellectual disability, in that: (i) candidates for genes sub-
ject to loss-of-function or other mutations may, in some
cases, be better-recognized though tests for recent adap-
tive evolution, given that such tests are strongly indicative
of functional differences between speciﬁc haplotypes or
alleles, and (ii) genes involved in the DNA repair and
Rho-GTPase pathways may represent especially strong
candidates for involvement in intellectual disability,
according to the analyses conducted here. More generally,
integration of evolutionary tools and perspectives into
studies dissecting the genetic bases of human intellectual
Human intellectual disability Crespi et al.
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into understanding both the evolution of human intelli-
gence and the causes of variation in intellectual abilities
within extant populations.
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